Feline heart disease comes in several forms, but the vast majority of cases seen in general practice fall under a group of conditions called cardiomyopathies. These affect the heart muscle directly and can impact how efficiently it pumps blood. Here are the most common types:
Hypertrophic Cardiomyopathy (HCM)
By far the most common form of heart disease in cats, HCM is characterised by thickening of the walls of the heart’s main pumping chamber (the left ventricle). This thickening reduces the heart’s ability to relax and fill properly, which in turn leads to poor circulation and potential fluid buildup. HCM is often genetic and tends to affect middle-aged to older cats, although it can occur at any age. Some breeds, like Maine Coons and Ragdolls, carry known genetic mutations linked to the disease.
Dilated Cardiomyopathy (DCM)
DCM involves thinning and weakening of the heart walls, which compromises the heart’s pumping ability. This condition used to be more common when commercial cat food lacked adequate taurine, an essential amino acid. Since taurine supplementation became standard in the 1980s, true DCM has become rare, but it can still occur, either as a nutritional deficiency or secondary to another condition.
Restrictive Cardiomyopathy (RCM)
In RCM, the heart muscle becomes stiff or fibrotic, limiting its ability to stretch and fill with blood between beats. Unlike HCM, the walls may not appear thickened on imaging, but the functional impairment can be just as serious. It often presents with congestive signs and may be more difficult to diagnose definitively without echocardiography.
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Less commonly diagnosed in cats, ARVC affects the right side of the heart, replacing healthy heart muscle with fatty or fibrous tissue. This condition can lead to irregular heart rhythms and may predispose the cat to sudden cardiac events.
Unclassified Cardiomyopathies
Sometimes, a cat presents with cardiac disease that doesn’t fit neatly into any of the above categories. In these cases, the condition is labelled “unclassified cardiomyopathy” and managed based on clinical signs and progression.